About: Apnimed, Inc. operates as a clinical pharmaceutical company that develops and manufactures novel oral therapies that address the neurobiology of sleep-related breathing diseases in global markets. It offers AD109, an oral therapy designed to treat obstructive sleep apnea (OSA) by targeting the underlying neuromuscular dysfunction. The company was incorporated in 2017 and is headquartered in Cambridge, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Latest price: $26.22 (-9.59%)
APMD NASDAQ Apnimed, Inc. Common Stock
Loading watchlist status…
Apnimed, Inc. Common Stock share price
APMD price activity
Last Price
$26.220
Change (24hr)
-2.78 USD (-9.59%)
Volume
1.51M
Volume (4w avg)
-
Open
$28.90
Day Range
$23.13 - $28.90
Previous Close
$29.00
Last Trade
21 Sep, 8:24 pm GMT+0
Delayed
21 Sep, 8:24 pm GMT+0
APMD price performance
2.58%
5D
-6.46%
1M
63.87%
YTD
63.87%
1Y
Delayed
21 Sep, 8:24 pm GMT+0
APMD Market Signals